Site icon Nairametrics

Transcorp Vs. UAC Nigeria – Who navigated better in 2023?

Transcorp Vs. UAC Nigeria

Story highlights


Since 2023, the Nigerian business environment has been turbulent, marked by macroeconomic challenges.

Amid these turbulent economic conditions, Nigerian conglomerates have showcased resilience and adaptability.

Two standout players; Transcorp Plc and UAC Nigeria, have notably weathered these challenges, achieving impressive financial performances.

Strong Pre-Tax Profit Growth

Transcorp Plc and UAC Nigeria have both experienced substantial growth in pre-tax profits despite the challenging economic backdrop.

News continues after this ad

News continues after this ad

Transcorp reported a significant 94% increase in pre-tax profit for the year 2023, amounting to N58.81 billion, with Q1 2024 continuing this upward trend at N45.685 billion.

Meanwhile, UAC of Nigeria’s pre-tax profit surged by an impressive 348.5% from 2022, transitioning from a loss of N4.822 billion to a profit of N11.984 billion in 2023.

The momentum carried forward into Q1 2024, with UAC Nigeria recording a promising N9.03 billion in pre-tax profit, a stark improvement from the N937 million loss in Q1 2023.

Profitability Sources

UAC Nigeria attributes its profitability to increased revenue across all segments due to a combination of volume growth and price increases, cost-saving measures implemented in the Animal Feeds and Other Edibles segment, and gains from the disposal of non-core property assets.

However, a review of the financial statements suggests that foreign exchange gains also played a significant role.

In contrast, Transcorp’s profitability appears to be driven more by robust core operational activities than by foreign exchange (FX) gains:

In the context of profitability and its sources, the distinction highlights Transcorp’s advantage in maintaining a more stable, sustainable, and reliable source of profitability compared to UAC Nigeria.

Despite their differences, both companies experienced positive impacts on their retained earnings and shareholders’ funds due to growth in profitability.

In terms of earnings per share, it appears UACN generated higher earnings per outstanding share compared to Transcorp.

In Q1 2024, Transcorp reported earnings per share (EPS) of 0.61, whereas UAC Nigeria (UACN) recorded an EPS of 1.85 during the same period.

This suggests that UACN’s profitability, relative to its number of shares, was more favourable than Transcorp’s during that quarter.

Investors often use EPS as a metric to assess a company’s profitability on a per-share basis and to evaluate its valuation.

Based on trailing twelve-month earnings per share (EPS), UAC Nigeria (UACN) is trading at lower earnings multiple of 2.7x, while Transcorp’s earnings multiple stands higher at 11x.

In essence, UACN’s lower earnings multiple suggests that it is priced more attractively relative to its earnings compared to Transcorp.

Investors may perceive UACN as potentially undervalued or having better earnings efficiency, making it a potentially more favourable investment choice based on this valuation metric alone

When comparing their price-to-book and price-to-sales ratios, UAC Nigeria (UACN) shows a lower price-to-book ratio of 0.69, while Transcorp’s ratio is higher at 2.7.

Similarly, UACN’s price-to-sales ratio is lower at 0.29, whereas Transcorp’s ratio stands higher at 1.73.

These metrics indicate that UACN’s stock is potentially undervalued relative to its book value and sales compared to Transcorp.

Investors might interpret this as UACN being undervalued based on its book value and sales per share.

Overall, UAC Nigeria appears to offer better valuation metrics with lower ratios, potentially indicating it is undervalued compared to Transcorp.

However, Transcorp’s profitability from core operations and higher earnings may appeal to investors looking for stability and growth in diversified sectors.

Investors should consider these factors alongside their own investment objectives, risk tolerance, and market outlook when evaluating which company aligns better with their investment strategy.

Each company’s financial health, growth prospects, and market position play crucial roles in determining their attractiveness as an investment opportunity.

Exit mobile version